Skip to main content
main-content

Expert opinion

Neuer Inhalt Free Registration

Gain full access to the latest clinical content available from Springer Nature

08-22-2017 | Retinopathy | Editorial | Article

Antivascular endothelial growth factor treatment for proliferative diabetic retinopathy: Perspective on the CLARITY study

In this editorial, Rishi Singh and colleagues provide their perspective on the future of proliferative diabetic retinopathy treatment following the completion of the CLARITY and Protocol S studies.

Authors:
Nathaniel B. Rieveschl, Felipe F. Conti, Rishi P. Singh

07-05-2017 | Prevention | Editorial | Article

Type 2 diabetes can be prevented in your patients

Editorial Board member Jay Shubrook and his colleague Alegria Cantillep discuss the National Diabetes Prevention Program, how you might find eligible patients, and how you can refer them to the program.

Authors:
Alegria Cantillep, Jay Shubrook DO

06-13-2017 | Type 2 diabetes | Editorial | Article

Is it harder to treat diabetes today?

Treating type 2 diabetes has become so complicated. Why is this so? Editorial Board member Jay Shubrook discusses the reasons and suggests ways to make diabetes treatment less overwhelming.

Author:
Jay Shubrook DO

05-08-2017 | Metformin | Editorial | Article

Metformin: What is new with this old medication?

With the arrival of slow-release formulations of metformin and the relaxation of guidelines concerning its use in patients with kidney disease, Carol Wysham explains how the population of patients who might benefit from this medication has expanded.

Author:
Carol Wysham MD

01-13-2017 | Cardiovascular outcomes | Editorial | Article

Clinical implications of cardiovascular outcomes trials in type 2 diabetes

What do the results of CVOTs mean for practicing clinicians? Editorial board member Carol Hatch Wysham reviews the latest evidence and guidelines for reducing CV risk in patients with type 2 diabetes.

Author:
Carol Wysham MD

Meet our Editorial Board

Lori BerardSanjay KalraJay ShubrookProfessor John WildingCarol Wysham

New Content Item Meet our Advisory Board

image credits